Tag: pharmaceuticals
-
Fox Foundation Funds New Genetic Variation Targets for Parkinson’s
A Parkinson’s disease organization is giving a grant to a neurodegenerative therapies developer that targets new groups of underlying disease-causing genetic changes.
-
Start-Up Licensing Antibody Eye Drops for Dry Eye Disease
An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease.
-
RSV Vaccine Breakthrough Examined at AAAS Meeting
As three vaccines against respiratory syncytial virus reach FDA review, a scientific conference explored a key breakthrough researchers achieved to get to this point.
-
Business-Academic Team to Create RNA Delivery for Cancer
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles.
-
mRNA Aerosol Delivered to Lungs to Treat Pneumonia
Messenger RNA, inhaled from an aerosol spray, is shown in lab rats with pneumonia to reduce inflammation, improve lung functions, and protect against further infections.
-
State Grant Supports Osteoarthritis Gene Therapy Trial
A California state agency is funding a clinical trial of an experimental gene therapy for reducing inflammation in knee joints of people with osteoarthritis.
-
Psychoactive Drug Start-Up Raises $40M in Early Funds
A new company is underway developing drugs to treat PTSD and other disorders with psychoactive compounds claimed to be safer than current psychedelics.
-
Bio-Electric Regeneration Company Adds $8M in Seed Funds
A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds.
-
Biotech Drug Shown to Kill Prostate Tumor Cells
Tests with lab mice show low doses of an experimental oral drug can selectively kill prostate cancer cells while not affecting surrounding healthy tissue.
-
Nasal Spray Reduces Flu Duration in Challenge Trial
An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus.